Reaction
Hepatitis C Rna Increased reporting signals
As of the last recalculation, Hepatitis C Rna Increased appears in 340 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is SOFOSBUVIR (PRR 173.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sofosbuvir | 48 | 173.3 | 173.7 |
| Ribavirin | 103 | 140.3 | 140.5 |
| Peginterferon Alfa-2A | 73 | 105.0 | 105.1 |
| Velpatasvir And Sofosbuvir | 13 | 64.4 | 64.5 |
| Glecaprevir And Pibrentasvir | 11 | 63.3 | 63.4 |
| Anti-Thymocyte Globulin (Rabbit) | 6 | 46.3 | 46.4 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 28.7 | 28.7 |
| Ledipasvir And Sofosbuvir | 6 | 19.4 | 19.4 |